Enovis Corp. (ENOV) fundamentals score
Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing, and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Healthcare · Listed on NYSE
Overall: 4.9 out of 10, Weak long-term fundamentals
- Growth: 4.0/10
- Profitability: 3.2/10
- Financial health: 3.4/10
- Earnings quality: 9.4/10
- Valuation: 6.7/10
Scores are calculated from Enovis Corp.’s SEC filings, using the 12 months through 2026-07. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10